TONIX Pharmaceuticals, Inc. to Ring the NASDAQ Stock Market Closing Bell

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ADVISORY, Aug. 9, 2013 (GLOBE NEWSWIRE) -- What: Tonix Pharmaceuticals [TNXP], a specialty pharmaceutical company developing novel treatments for challenging disorders of the central nervous system, including fibromyalgia and post-traumatic stress disorder, will visit the NASDAQ MarketSite in Times Square in celebration of its listing on The NASDAQ Stock Market, which occurred today, August 9.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC